# 0409-7620-03 · Heparin Sodium Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker

For 0409-7620-03 · Heparin Sodium Injection · Hospira, Inc., a Pfizer Company, package ndc is 0409-7620-03; generic name is Heparin Sodium Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Available, recorded from its source on 2026-09-01; source re-checked 2026-09-10.

- **Package NDC:** 0409-7620-03 _(verified: appears in the quote below)_
- **Generic name:** Heparin Sodium Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 11/14/2017 _(verified: appears in the quote below)_
- **Last update date:** 08/24/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3213 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Hematology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "11/14/2017", "package_ndc": "0409-7620-03", "generic_name": "Heparin Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "presentation": "Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)", "update_type": "Reverified", "initial_posting_date": "11/14/2017", "package_ndc": "0409-7620-03", "generic_name": "Heparin Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "08/24/2026", "therapeutic_category": [ "Hematology" ], "status": "Current", "dosage_form": "Injection"

### Status

> "presentation": "Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)", "update_type": "Reverified", "initial_posting_date": "11/14/2017", "package_ndc": "0409-7620-03", "generic_name": "Heparin Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "08/24/2026", "therapeutic_category": [ "Hematology" ], "status": "Current", "dosage_form": "Injection"

### Last update date

> "presentation": "Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)", "update_type": "Reverified", "initial_posting_date": "11/14/2017", "package_ndc": "0409-7620-03", "generic_name": "Heparin Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "08/24/2026", "therapeutic_category": [ "Hematology" ], "status": "Current", "dosage_form": "Injection"

### Dosage form

> "presentation": "Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)", "update_type": "Reverified", "initial_posting_date": "11/14/2017", "package_ndc": "0409-7620-03", "generic_name": "Heparin Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "08/24/2026", "therapeutic_category": [ "Hematology" ], "status": "Current", "dosage_form": "Injection"

### Therapeutic category

> "presentation": "Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-7620-03)", "update_type": "Reverified", "initial_posting_date": "11/14/2017", "package_ndc": "0409-7620-03", "generic_name": "Heparin Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "08/24/2026", "therapeutic_category": [ "Hematology" ], "status": "Current", "dosage_form": "Injection"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-10. Review by: 2026-09-13.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).